StockWatch
·

JENBURKT PHARMACEUTICALS LTD. Q4 FY26 Results

JENBURPHQ4 FY26 Results
Filing
MetricValue ( Cr)Q3 FY26Q4 FY25
Revenue44.633.7%8.7%
Total Income48.989.2%14.1%
Expenditure31.3214.3%0.7%
PBT13.7165.2%15.8%
Net Profit10.8582.9%27.1%
OPM23.07%5.80pp3.38pp
NPM22.15%8.92pp2.26pp
EPS24.5882.9%27.1%
View full financials

Informational and educational content only. Not investment advice.